What is the address of TOGIMED?

The registered office of TOGIMED is located at Rue Vivier,Sart-Eustache 9, 5070 Fosses-la-Ville.

Is TOGIMED still active?

Yes. According to the CBE (31 October 2026) TOGIMED is active, legal situation “Normale toestand”, started on 12 February 2009.

Is TOGIMED registered on Peppol?

No, TOGIMED is currently not registered on the Peppol network.

What is the enterprise number of TOGIMED?

The enterprise number of TOGIMED is BE0809767381.

When was TOGIMED founded?

TOGIMED was founded on 12 February 2009.

Is TOGIMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 February 2009; 5 annual accounts filed, latest fiscal year 2025.

How much profit did TOGIMED make in 2025?

TOGIMED posted a profit after taxes of € 217,168 in financial year 2025.

What is the revenue of TOGIMED?

As a small company, TOGIMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 327,449.

TOGIMED (Private Limited) - Fosses-la-Ville

Dossier TOGIMED, printed on 31 October 2026 from databakkes.be/en/0809767381/togimed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

TOGIMED from Fosses-la-Ville, company number BE0809767381, closed financial year 2025 with a result of € 217,168 after tax. For that financial year TOGIMED recorded a gross margin of € 327,449 and equity of € 498,932. Compared with financial year 2024, the result moved from € 116,841 to € 217,168. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.

What it is worth Healthy

€ 498,932

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 217,168

▲ 86% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 174,244

▼ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 258,302 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 19,938

▼ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 10,875

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 49,498

▲ 111% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 180,680 Gross margin 2022: € 180,680 First fiscal year in the series	€ 202,651 Gross margin 2023: € 202,651 ▲ 12% vs 2022 (€ 180,680) Favourable step	€ 198,736 Gross margin 2024: € 198,736 ▼ 2% vs 2023 (€ 202,651) Unfavourable step	€ 327,449 Gross margin 2025: € 327,449 ▲ 65% vs 2024 (€ 198,736) Favourable step	▲ 65%
Profit after taxes	€ 106,142 Profit after taxes 2022: € 106,142 First fiscal year in the series	€ 117,345 Profit after taxes 2023: € 117,345 ▲ 11% vs 2022 (€ 106,142) Favourable step	€ 116,841 Profit after taxes 2024: € 116,841 Unchanged (€ 117,345) Unfavourable step	€ 217,168 Profit after taxes 2025: € 217,168 ▲ 86% vs 2024 (€ 116,841) Favourable step	▲ 86%
Equity	€ 340,880 Equity 2022: € 340,880 First fiscal year in the series	€ 423,225 Equity 2023: € 423,225 ▲ 24% vs 2022 (€ 340,880) Favourable step	€ 540,066 Equity 2024: € 540,066 ▲ 28% vs 2023 (€ 423,225) Favourable step	€ 498,932 Equity 2025: € 498,932 ▼ 8% vs 2024 (€ 540,066) Unfavourable step	▼ 8%
Total debts	€ 124,244 Total debts 2022: € 124,244 First fiscal year in the series	€ 70,937 Total debts 2023: € 70,937 ▼ 43% vs 2022 (€ 124,244) Favourable step	€ 44,053 Total debts 2024: € 44,053 ▼ 38% vs 2023 (€ 70,937) Favourable step	€ 303,118 Total debts 2025: € 303,118 ▲ € 259,065 vs 2024 (€ 44,053) Unfavourable step	▲ € 259,065
Cash	€ 240,031 Cash 2022: € 240,031 First fiscal year in the series	€ 95,706 Cash 2023: € 95,706 ▼ 60% vs 2022 (€ 240,031) Unfavourable step	€ 396,386 Cash 2024: € 396,386 ▲ € 300,679 vs 2023 (€ 95,706) Favourable step	€ 174,244 Cash 2025: € 174,244 ▼ 56% vs 2024 (€ 396,386) Unfavourable step	▼ 56%
Land & buildings	€ 147,771 Land & buildings 2022: € 147,771 First fiscal year in the series	€ 137,412 Land & buildings 2023: € 137,412 ▼ 7% vs 2022 (€ 147,771) Unchanged	€ 123,705 Land & buildings 2024: € 123,705 ▼ 10% vs 2023 (€ 137,412) Unchanged	-
Retained profit	€ 303,780 Retained profit 2022: € 303,780 First fiscal year in the series	€ 386,125 Retained profit 2023: € 386,125 ▲ 27% vs 2022 (€ 303,780) Favourable step	€ 502,966 Retained profit 2024: € 502,966 ▲ 30% vs 2023 (€ 386,125) Favourable step	€ 461,832 Retained profit 2025: € 461,832 ▼ 8% vs 2024 (€ 502,966) Unfavourable step	▼ 8%
Dividend	€ 105,582 Dividend 2022: € 105,582 First fiscal year in the series	€ 35,000 Dividend 2023: € 35,000 ▼ 67% vs 2022 (€ 105,582) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 35,000) Unchanged	€ 258,302 Dividend 2025: € 258,302 Unchanged (€ 0) Unchanged
Balance sheet total	€ 465,123 Balance sheet total 2022: € 465,123 First fiscal year in the series	€ 494,162 Balance sheet total 2023: € 494,162 ▲ 6% vs 2022 (€ 465,123) Unchanged	€ 584,118 Balance sheet total 2024: € 584,118 ▲ 18% vs 2023 (€ 494,162) Unchanged	€ 802,049 Balance sheet total 2025: € 802,049 ▲ 37% vs 2024 (€ 584,118) Unchanged	▲ 37%

Key figures of TOGIMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to TOGIMED?

What happened at TOGIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 17, 2026 New annual accounts for financial year 2025: profit of € 217,168 (▲ 86% vs 2024). filed late Source: NBB ↗
Feb 12, 2009 Start of the company according to the CBE. KBO

In short

From € 106,142 profit in 2022 to € 217,168 profit in 2025.

Paid € 238,899 in corporate taxes since 2022.

Best year ever: 2025, with € 217,168 profit.

Paid out € 398,884 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Vivier,Sart-Eustache 9

5070 Fosses-la-Ville

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0809.767.381
VAT number: BE 0809.767.381
Registered office: Rue Vivier,Sart-Eustache 9, 5070 Fosses-la-Ville
Names & denominations: TOGIMED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 February 2009
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

TOGIMED